<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16(1)</volume><submitter>Sergi B</submitter><journal>Cell death &amp; disease</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12334744</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Epidrug screening identifies type I PRMT inhibitors as modulators of lysosomal exocytosis and drug sensitivity in cancers</pubmed_title><pmcid>PMC12334744</pmcid><pubmed_authors>Sergi B</pubmed_authors><pubmed_authors>Yuksel-Catal N</pubmed_authors><pubmed_authors>Ozcan S</pubmed_authors><pubmed_authors>Acilan C</pubmed_authors><pubmed_authors>Kiselyov K</pubmed_authors><pubmed_authors>Syed H</pubmed_authors><pubmed_authors>Duvvuri U</pubmed_authors></additional><is_claimable>false</is_claimable><name>Epidrug screening identifies type I PRMT inhibitors as modulators of lysosomal exocytosis and drug sensitivity in cancers</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-05-01T08:51:31.287Z</modification><creation>2026-04-07T16:46:38.131Z</creation></dates><accession>S-EPMC12334744</accession><cross_references/></HashMap>